Investor
The iRhythm Technologies founder's new startup will use these funds to wrap up clinical testing of its device, and push toward a commercial launch.
The funds will help the New York City-based platform extend its growth and deliver new product offerings.
The new funds will be used to expand its coverage outside of New York.
IVP led the round, which adds to the company's existing $100 million in equity investments.
The round was led by Seraph Group with participation from Aphelion Capital, SV Tech Ventures and Shangbay Capital.
The startup initially landed 'seven-digit' investment from Corecam at the end of last year.
The funds will support expansion into new markets, as well as product launches and general scaling of its business.
GSR Venture US led the round with participation from Arsenal Growth and existing investors.
The collection of B2B AI companies already counts Concerto HealthAI among its numbers.
After monitoring the situation for weeks, CEO Hal Wolf says the 2020 HIMSS Global Health Conference & Exhibition will not proceed as hoped, given the health risks posed to attendees.